Kamron Laboratories Ltd

KAMRLAB
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2 cr, stock is ranked 3,846
Low RiskStock is 1.28x as volatile as Nifty
5.040.00 (+0.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2 cr, stock is ranked 3,846
Low RiskStock is 1.28x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
-2.30
PB RatioPB Ratio
1.53
Dividend YieldDiv. Yield
Sector PESector PE
38.07
Sector PBSector PB
5.10
Sector Div YldSctr Div Yld
0.67%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Kamron Laboratories is engaged in the manufacturing and trading of pharmaceutical products.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20182019202020218.315.8414.806.330.000.04-3.77-1.28
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 1.01%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Result 
Announced OnNov 13, 2021

KAMRON LABORATORIES LTD. - 524604 - Results-Financial Results For The Quarter Ended On September 30, 2021 | Download

KAMRON LABORATORIES LTD. - 524604 - Results-Financial Results For The Quarter Ended On September 30, 2021 | Download

Result 
Announced OnNov 13, 2021

Kamron Laboratories Ltd - 524604 - Results-Financial Results For The Quarter Ended On September 30, 2021 | Download

Kamron Laboratories Ltd - 524604 - Results-Financial Results For The Quarter Ended On September 30, 2021 | Download

Result 
Announced OnNov 13, 2021

KAMRON LABORATORIES LTD. - 524604 - Board Meeting Outcome for Submission Of Un-Audited Financial Results For The Quarter Ended On 30Th September, 2021 | Download

KAMRON LABORATORIES LTD. - 524604 - Board Meeting Outcome for Submission Of Un-Audited Financial Results For The Quarter Ended On 30Th September, 2021 | Download

See all events